Eichhorst, Barbara F <br/><br/>
Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia.  [electronic resource] 

 -  Blood  Feb 2006 
 - 885-91 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2005-06-2395  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Aged<br/>Antineoplastic Agents, Alkylating--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Infections--etiology<br/>Infusions, Intravenous<br/>Leukemia, Lymphocytic, Chronic, B-Cell--complications<br/>Leukopenia--chemically induced<br/>Male<br/>Middle Aged<br/>Remission Induction<br/>Retrospective Studies<br/>Thrombocytopenia--chemically induced<br/>Vidarabine--administration & dosage